Vanguard Group Inc Lantern Pharma Inc. Put Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LTRN
# of Institutions
38Shares Held
1.06MCall Options Held
124KPut Options Held
22.2K-
New Edge Advisors, LLC New Orleans, LA161KShares$735,2360.01% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$400,1720.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny65.7KShares$300,9060.0% of portfolio
-
Cm Management, LLC65KShares$297,7000.5% of portfolio
-
Redmond Asset Management, LLC Henrico, VA40.5KShares$185,3150.12% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $49.6M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...